<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Exercise capacity and VO2 in heart failure
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Exercise capacity and VO2 in heart failure
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Exercise capacity and VO2 in heart failure
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ileana L Piña, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen S Gottlieb, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Todd F Dardas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 21, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Limitation of exercise capacity is one of the cardinal manifestations of heart failure (HF), varying directly with the severity of the disease. Thus, decreased maximal exercise capacity is associated with decreased patient survival and impairment of quality of life. Exercise training may have a variety of benefits, including an improvement in quality of life, reduced hospitalization, and improved survival. (See
         <a class="medical medical_review" href="/z/d/html/3472.html" rel="external">
          "Cardiac rehabilitation in patients with heart failure"
         </a>
         .)
        </p>
        <p>
         The methods used to measure exercise capacity, the factors that limit exercise capacity in HF, and the use of measurement of peak exercise capacity (also called functional exercise testing) to predict prognosis will be reviewed here. This discussion is generally consistent with the 2000 recommendations published by the European Society of Cardiology and the 2014 update including the expanding role of cardiopulmonary testing [
         <a href="#rid1">
          1,2
         </a>
         ]. This discussion is also consistent with the 2010 clinician’s guide to cardiopulmonary testing and the 2012 clinical recommendations for specific populations, including HF, published by the American Heart Association (AHA) [
         <a href="#rid3">
          3,4
         </a>
         ]. Cardiopulmonary exercise testing and the effects of exercise training in patients with HF are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3465.html" rel="external">
          "Cardiopulmonary exercise testing in cardiovascular disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3472.html" rel="external">
          "Cardiac rehabilitation in patients with heart failure"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          MEASUREMENT OF EXERCISE CAPACITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Peak exercise capacity is defined as "the maximum ability of the cardiovascular system to deliver oxygen to exercising skeletal muscle and of the exercising muscle to extract oxygen from the blood" [
         <a href="#rid5">
          5
         </a>
         ]. As a result, exercise tolerance is determined by three factors: pulmonary gas exchange (including ventilation); cardiovascular performance, including the peripheral vascular tree; and skeletal muscle metabolism including oxygen extraction. (See
         <a class="medical medical_review" href="/z/d/html/1433.html" rel="external">
          "Exercise physiology"
         </a>
         .)
        </p>
        <p>
         While the New York Heart Association (NYHA) class is in fact a clinical estimation of activity tolerance, it is a highly subjective one and fails to discriminate or reflect smaller changes in function and important differences within each class level. Hence, a more objective measure is needed for prognosis testing beyond a clinical opinion (ie, peak VO
         <sub>
          2
         </sub>
         ).
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Peak VO2
         </span>
         <span class="headingEndMark">
          —
         </span>
         Exercise capacity can be quantitated clinically by measurement of oxygen uptake (VO
         <sub>
          2
         </sub>
         ), carbon dioxide production (VCO
         <sub>
          2
         </sub>
         ), and minute ventilation [
         <a href="#rid6">
          6
         </a>
         ]. These parameters are measured during exercise with rapidly responding gas analyzers capable of breath-by-breath determination of O
         <sub>
          2
         </sub>
         and CO
         <sub>
          2
         </sub>
         concentrations in inspired and expired air, respectively. The maximal oxygen uptake (VO
         <sub>
          2
         </sub>
         max) eventually reaches a plateau despite increasing workload (
         <a class="graphic graphic_figure graphicRef62094" href="/z/d/graphic/62094.html" rel="external">
          figure 1
         </a>
         ). Not surprisingly, VO
         <sub>
          2
         </sub>
         max has a strong linear correlation with both cardiac output and skeletal muscle blood flow (
         <a class="graphic graphic_figure graphicRef65079" href="/z/d/graphic/65079.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/3465.html" rel="external">
          "Cardiopulmonary exercise testing in cardiovascular disease"
         </a>
         ). The peak VO
         <sub>
          2
         </sub>
         divided by the heart rate (peak VO
         <sub>
          2
         </sub>
         /HR) is called the oxygen pulse and is an indirect measure of stroke volume.
        </p>
        <p>
         The relationship between cardiac output and O
         <sub>
          2
         </sub>
         uptake (or oxygen consumption) also forms the basis for the Fick equation used to measure cardiac output:
        </p>
        <div class="formulaContainer">
         <div class="formula">
          <p>
           Cardiac output   =   O
           <sub>
            2
           </sub>
           uptake (VO
           <sub>
            2
           </sub>
           )  /  Arteriovenous O
           <sub>
            2
           </sub>
           difference (AO
           <sub>
            2
           </sub>
           -  VO
           <sub>
            2
           </sub>
           )
          </p>
         </div>
        </div>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Ventilatory threshold
         </span>
         <span class="headingEndMark">
          —
         </span>
         The ventilatory threshold (VT), formerly referred to as the anaerobic threshold (AT), is another index used to estimate exercise capacity. It is defined as the point at which minute ventilation increases disproportionately relative to VO
         <sub>
          2
         </sub>
         , a response that is generally seen at 60 to 70 percent of VO
         <sub>
          2
         </sub>
         max (
         <a class="graphic graphic_figure graphicRef62094" href="/z/d/graphic/62094.html" rel="external">
          figure 1
         </a>
         ). The VT is a reflection of the disproportionate increase in lactic acid production by working muscles. It can be used to distinguish between noncardiac (pulmonary or musculoskeletal) and cardiac causes of exercise limitation, since patients who fatigue prior to reaching VT are likely to have a noncardiac problem [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Six-minute walk test
         </span>
         <span class="headingEndMark">
          —
         </span>
         The six-minute walk test is a useful, simple, and inexpensive test that correlates with VO
         <sub>
          2
         </sub>
         max and outcomes and has been used in clinical trials [
         <a href="#rid8">
          8-11
         </a>
         ]. This submaximal exercise test measures the distance ambulated on a level hallway surface during six minutes as described in the 2002
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.thoracic.org%2Fstatements%2Fresources%2Fpfet%2Fsixminute.pdf&amp;token=VPTwCqdXMtl9pxvxwTYAK8LUGUKTEaQBzbMVfdJWOx2%2Bo7PPoFIkJGhnTJVHP8NKL6Xfu%2BVPRtT63l2TCUiTUq8AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=3503" target="_blank">
          American Thoracic Society (ATS) statement on the six-minute walk test.
         </a>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          EXERCISE CAPACITY IN HF
         </span>
         <span class="headingEndMark">
          —
         </span>
         Exercise capacity is reduced even in mild HF. The cardiac output may be relatively normal at rest, but is usually unable to increase adequately with even mild exertion [
         <a href="#rid7">
          7
         </a>
         ]. As in normal subjects, peak VO
         <sub>
          2
         </sub>
         in HF is directly related to peak exercise cardiac output and muscle blood flow (
         <a class="graphic graphic_figure graphicRef65079" href="/z/d/graphic/65079.html" rel="external">
          figure 2
         </a>
         ). However, the inability to appropriately increase cardiac output results in an insufficient increase in perfusion to exercising muscle, which can cause early anaerobic metabolism, muscle fatigue, and eventual muscle wasting [
         <a href="#rid12">
          12
         </a>
         ]. Since HF patients often do not attain a true VO
         <sub>
          2
         </sub>
         max, the term "peak VO
         <sub>
          2
         </sub>
         " is often used.
        </p>
        <p>
         Several factors contribute to the inadequate response to exercise in patients with HF [
         <a href="#rid13">
          13
         </a>
         ]. A review of exercise intolerance in HF emphasized factors in addition to diminished cardiac reserve that contribute to exercise intolerance [
         <a href="#rid14">
          14
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The inotropic and chronotropic response to catecholamines is reduced; this defect is due at least in part to downregulation of beta receptors and the lower workload achieved by patients with HF [
         <a href="#rid15">
          15,16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Augmentation of stroke volume via the Starling mechanism may be limited by diastolic dysfunction (changes in the pressure/volume curve) or pericardial constraint.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In contrast to people without HF, exercise in patients with HF is associated with an elevation in the pulmonary wedge pressure, reflecting high left atrial pressure. This can exacerbate pulmonary congestion, thereby causing dyspnea and limiting exercise capacity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inadequate ventilation and O
         <sub>
          2
         </sub>
         /CO
         <sub>
          2
         </sub>
         diffusion across the blood-alveolar barrier coupled with insufficient respiratory muscle strength to maintain the higher demands of activity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Impaired O
         <sub>
          2
         </sub>
         carrying capacity of the blood and impaired O
         <sub>
          2
         </sub>
         diffusion and extraction in skeletal muscle. This parameter may explain exercise fatigue in patients with HF and anemia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Both biochemical and functional abnormalities in skeletal muscle are often present, limiting muscle metabolic capacity (
         <a class="graphic graphic_figure graphicRef54643" href="/z/d/graphic/54643.html" rel="external">
          figure 3
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The presence of pulmonary hypertension and increased pulmonary vascular resistance can reduce the cardiac output response to exercise, impairing exercise capacity [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Concurrent valve disease (eg, mitral regurgitation) may be present, limiting the increase in forward output when the regurgitation becomes severe.
        </p>
        <p>
        </p>
        <p>
         Patients with HF with preserved ejection fraction (HFpEF) can have as severe exercise intolerance as patients with HF with reduced ejection fraction (HFrEF). Central (reduced O
         <sub>
          2
         </sub>
         transport) and peripheral factors contribute to exercise intolerance in both types of HF. Some data suggest that peripheral factors may be particularly important in patients with HFpEF [
         <a href="#rid18">
          18
         </a>
         ]. The prognostic value of peak VO
         <sub>
          2
         </sub>
         testing in patients with HFpEF is discussed below. (See
         <a class="local">
          'Type of HF'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Pulmonary dysfunction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reduced respiratory muscle endurance may be present as part of the generalized skeletal myopathy in patients with HF [
         <a href="#rid19">
          19
         </a>
         ]. This abnormality may contribute to the symptoms of fatigue and dyspnea on exertion.
        </p>
        <p>
         The diaphragm shows a different adaptation from skeletal and respiratory muscle. There is a shift from fast to slow fibers with an increase in oxidative capacity and a decrease in glycolytic capacity [
         <a href="#rid20">
          20
         </a>
         ]. These changes are similar to those seen in the limb muscles that occur with endurance training, suggesting that they result from the increased work of breathing.
        </p>
        <p>
         There are also changes in pulmonary function in HF. Even in the absence of pulmonary congestion, HF is associated with impaired pulmonary diffusion [
         <a href="#rid21">
          21
         </a>
         ] and an exaggerated increase in minute ventilation in response to exercise, out of proportion to the increase in carbon dioxide production [
         <a href="#rid22">
          22,23
         </a>
         ]. Hyperventilation is primarily due to ventilation/perfusion mismatching, the severity of which is related to the severity of the HF [
         <a href="#rid23">
          23
         </a>
         ]. The combination of increased ventilation and normal gas exchange (unless limited by pulmonary congestion) means that arterial hypoxia does not generally occur during exercise.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          USE OF PEAK VO2
         </span>
        </p>
        <p class="headingAnchor" id="H32497339">
         <span class="h2">
          Predictive value
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with HF who require an objective measure of exercise capacity, we prefer the measurement of peak VO
         <sub>
          2
         </sub>
         (ie, maximal oxygen uptake). This parameter is a surrogate marker for the maximal cardiac output that an individual can achieve. Patients with a peak VO
         <sub>
          2
         </sub>
         ≤10 mL/kg/min have the worst prognosis (normal value with exercise is above 20 mL/kg/min) (
         <a class="graphic graphic_figure graphicRef63516" href="/z/d/graphic/63516.html" rel="external">
          figure 4
         </a>
         ).
        </p>
        <p>
         The predictive value of peak VO
         <sub>
          2
         </sub>
         is valid only in patients whose exercise capacity is limited by HF. In patients with other limiting comorbidities, additional or alternative exercise parameters may be helpful.
        </p>
        <p>
         In addition, since peak VO
         <sub>
          2
         </sub>
         is influenced by age, sex, and body weight, the percent predicted value may be a more reliable indicator of prognosis [
         <a href="#rid24">
          24,25
         </a>
         ]. Values of 50 percent or more are associated with an excellent short-term prognosis.
        </p>
        <p>
         The potential utility of percent predicted peak VO
         <sub>
          2
         </sub>
         was illustrated in a study of exercise testing in 181 ambulatory patients with HF who were being considered for transplantation [
         <a href="#rid25">
          25
         </a>
         ]. Survival in patients who achieved ≤50 percent predicted VO
         <sub>
          2
         </sub>
         max was significantly lower than in those who achieved more than 50 percent predicted VO
         <sub>
          2
         </sub>
         max at one (74 versus 98 percent) and two years (43 versus 90 percent). Use of the percent predicted VO
         <sub>
          2
         </sub>
         max provided additional prognostic information to the absolute peak VO
         <sub>
          2
         </sub>
         .
        </p>
        <p class="headingAnchor" id="H121186574">
         <span class="h2">
          Use
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to its utility to predict prognosis in patients with HF, the peak VO
         <sub>
          2
         </sub>
         is an important component in the evaluation of patients for cardiac transplantation. (See
         <a class="medical medical_review" href="/z/d/html/3528.html" rel="external">
          "Heart transplantation in adults: Indications and contraindications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Limitations
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prognostic value of peak VO
         <sub>
          2
         </sub>
         has several limitations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The data correlating peak VO
         <sub>
          2
         </sub>
         and outcomes were derived before the use of therapies that improve survival in patients with advanced HF, such as beta blockers. With such therapies, peak VO
         <sub>
          2
         </sub>
         still predicts survival, but a peak VO
         <sub>
          2
         </sub>
         cut point lower than 14 mL/kg/min may be warranted as an indication for referral for transplantation. The ISHLT Guidelines provide guidance for patients on beta blockers suggesting a peak VO
         <sub>
          2
         </sub>
         cutoff of &lt;12 mL/kg/min in contrast to &lt;14 mL/kg/min for those not on a beta blocker (Class I, Level of Evidence: B) [
         <a href="#rid26">
          26
         </a>
         ]. However, peak VO
         <sub>
          2
         </sub>
         must be considered in the setting of the patient’s age and sex, given that age is the most powerful predictor of peak VO
         <sub>
          2
         </sub>
         [
         <a href="#rid27">
          27
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3528.html" rel="external">
          "Heart transplantation in adults: Indications and contraindications", section on 'Peak VO2'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The predictive value of peak VO
         <sub>
          2
         </sub>
         is accurate only when exercise capacity is limited by HF. Factors that can prematurely terminate the test must be excluded, including significant peripheral muscular deconditioning, peripheral artery disease, arthritis, angina pectoris, or low patient motivation. In such situations, patients are unable to achieve a true VO
         <sub>
          2
         </sub>
         max. The proper interpretation of the peak VO
         <sub>
          2
         </sub>
         requires that the patient achieve the ventilatory threshold (VT), indicating that the level of exercise performed exceeded that which can be supported by the cardiovascular system on an aerobic basis and is sufficient to render a test interpretation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Peak VO
         <sub>
          2
         </sub>
         may be less useful in females than in males. The influence of sex on both peak VO
         <sub>
          2
         </sub>
         and its prognostic value was illustrated in a series of 594 patients with advanced HF (28 percent females) [
         <a href="#rid28">
          28
         </a>
         ]. Although females were younger (49 versus 53 years in males) and had better systolic function (mean left ventricular ejection fraction [LVEF] 29 versus 25 percent), the mean peak VO
         <sub>
          2
         </sub>
         was lower in females than in males (14.0 versus 16.6 percent, respectively). Despite the lower peak VO
         <sub>
          2
         </sub>
         , females had a higher one-year transplant-free survival (94 versus 81 percent). A better measure of exercise capacity in females may be the percent predicted peak VO
         <sub>
          2
         </sub>
         for age and body weight. In the HF-ACTION trial, the peak VO
         <sub>
          2
         </sub>
         for females did correlate with New York Heart Association (NYHA) class but was considerably lower than that for the males [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The absolute peak VO
         <sub>
          2
         </sub>
         is also influenced by such factors as age and body weight. The percent predicted peak VO
         <sub>
          2
         </sub>
         corrects for these factors and may be a more accurate determinant of prognosis [
         <a href="#rid24">
          24,25
         </a>
         ]. HF centers have been using the percent predicted peak VO
         <sub>
          2
         </sub>
         to assess prognosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exercise oscillatory ventilation is often observed in patients with severe HF and may make the determination of peak VO
         <sub>
          2
         </sub>
         more challenging. However, oscillatory ventilation itself may be a marker of more severe disease and worse prognosis [
         <a href="#rid30">
          30-32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1385763575">
         <span class="h2">
          Type of HF
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cardiopulmonary testing cannot reliably differentiate HFrEF from HFpEF. Studies shown that CPX variables are equally abnormal in HFpEF patients compared with HFrEF patients when matched by clinical characteristics and that the VO
         <sub>
          2
         </sub>
         can predict outcomes in this population, including readmissions [
         <a href="#rid33">
          33,34
         </a>
         ]. In addition, there seems to be a correlation between peak VO
         <sub>
          2
         </sub>
         and other physiologic variables, such as N-terminal pro-B-type natriuretic peptide [
         <a href="#rid33">
          33
         </a>
         ]. However, in HFpEF patients, the source of impaired VO
         <sub>
          2
         </sub>
         may be more strongly related to abnormal arteriovenous O
         <sub>
          2
         </sub>
         difference with reduced maximal oxidative capacity in skeletal muscle [
         <a href="#rid35">
          35-37
         </a>
         ].
        </p>
        <p>
         While the multiple sources of exercise intolerance have been extensively studied in HFrEF, those of HFpEF are less well-accepted or studied. Large database cohorts are showing a strong association with obesity and low levels of leisure-time physical activity with HFpEF. Limitations of exercise capacity in HFpEF may include poor skeletal muscle function and fat/muscle ratio, greater prevalence of right ventricular dysfunction, and both systemic and pulmonary hypertension. Obesity as a phenotype of the HFpEF syndrome is also associated with poor ventilation from reduced respiratory muscle strength [
         <a href="#rid14">
          14,38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Additional predictors
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prognostic value of peak VO
         <sub>
          2
         </sub>
         may be enhanced by additional measures of the physiologic response to exercise:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systolic blood pressure – The predictive value of peak exercise systolic blood pressure was illustrated in a three-year follow-up study of 500 patients with HF referred for transplantation [
         <a href="#rid39">
          39
         </a>
         ]. On multivariate analysis, peak exercise systolic blood pressure and the percent predicted VO
         <sub>
          2
         </sub>
         max were the two most important predictors for the combined end point of death or listing for transplant. The three-year survival rate for patients with a peak exercise VO
         <sub>
          2
         </sub>
         ≤14 mL/min/kg who were unable to reach a peak exercise systolic blood pressure of 120 mmHg was 55 percent compared with 83 percent for those able to achieve this blood pressure (
         <a class="graphic graphic_figure graphicRef70524" href="/z/d/graphic/70524.html" rel="external">
          figure 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiac output – The incremental predictive survival value of the cardiac output response to maximal exercise was illustrated in the following studies:
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a study 185 patients with advanced HF, a "normal" cardiac output response to exercise provided incremental information above the absolute VO
         <sub>
          2
         </sub>
         determination in predicting survival [
         <a href="#rid40">
          40
         </a>
         ]. This was especially true in patients with VO
         <sub>
          2max
         </sub>
         responses below 10 mL/min/kg.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In another study, two hundred and nineteen patients underwent exercise testing while being monitored with a Swan-Ganz catheter [
         <a href="#rid41">
          41
         </a>
         ]. Peak exercise stroke work index was the most powerful prognostic variable; the two-year survival for those with a stroke work index ≤30 g/m
         <sup>
          2
         </sup>
         was 54 percent compared with 91 percent for those with an index &gt;30 g/m
         <sup>
          2
         </sup>
         (p &lt;0.0001). Among patients with a relatively low peak VO
         <sub>
          2
         </sub>
         , those who had a normal cardiac output response to exercise had an excellent two year survival (87 versus 58 percent in the others) (
         <a class="graphic graphic_figure graphicRef71980" href="/z/d/graphic/71980.html" rel="external">
          figure 6
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, invasive hemodynamic exercise determinations are not practical for routine evaluation. Furthermore, a smaller study found that only 6 percent of patients had a normal response to exercise, suggesting that this approach may not be cost-effective [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ventilatory threshold – It has been suggested that the VT might be more predictive than the peak VO
         <sub>
          2
         </sub>
         because it is less prone to error. In one report of 223 consecutive patients with HF, a VT &lt;11 mL/kg/min was more predictive of six-month mortality than a peak VO
         <sub>
          2
         </sub>
         ≤14 mL/kg/min (odds ratio [OR] 5.3 versus 3.4) [
         <a href="#rid43">
          43
         </a>
         ]. The risk is almost doubled when a low VT was combined with impaired ventilatory efficiency (OR 9.6).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stress induced LV dilation – One noninvasive technique that may be helpful, particularly in patients with an idiopathic dilated cardiomyopathy who have a borderline VO
         <sub>
          2
         </sub>
         max (10 to 14 mL/kg/min) is
         <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">
          dobutamine
         </a>
         echocardiography. An increase in LV end-diastolic diameter and wall stress in such patients is predictive of mortality [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ventilatory response – There has been increased interest in using the VE/VCO
         <sub>
          2
         </sub>
         slope for prognosis. During cardiopulmonary exercise testing, a close linear relationship exists between the production of CO
         <sub>
          2
         </sub>
         (VCO
         <sub>
          2
         </sub>
         ) and minute ventilation (VE). The slope of the regression line relating CO
         <sub>
          2
         </sub>
         production and minute ventilation (VE/VCO
         <sub>
          2
         </sub>
         ) can be used to describe the ventilatory response to exercise. Some studies have now shown that the combination of the VE/VCO
         <sub>
          2
         </sub>
         slope added to the peak VO
         <sub>
          2
         </sub>
         may better predict outcome. Others have reported that the ratio is superior to peak VO
         <sub>
          2
         </sub>
         alone [
         <a href="#rid2">
          2
         </a>
         ]. There is general agreement that the measurement of VE/VCO
         <sub>
          2
         </sub>
         during the entire exercise time is more physiologic. The VE/VCO
         <sub>
          2
         </sub>
         slope is discussed further below. (See
         <a class="local">
          'Ventilatory efficiency'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H32496427">
         <span class="h1">
          OTHER PREDICTIVE EXERCISE PARAMETERS
         </span>
        </p>
        <p class="headingAnchor" id="H32497388">
         <span class="h2">
          Six-minute walk test
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with HF who cannot perform a peak VO
         <sub>
          2
         </sub>
         test, we typically measure exercise capacity with a six-minute walk test (6MWT) (
         <a class="graphic graphic_table graphicRef90285" href="/z/d/graphic/90285.html" rel="external">
          table 1
         </a>
         ). The 6MWT does not require the use of specialized equipment, can be performed in patients who cannot exercise on a treadmill or cycle, and provides prognostic information. The 6MWT is particularly useful in patients with New York Heart Association (NYHA) class III to IV HF symptoms in whom the test result is reproducible and correlates with self-reported health status (eg, activities of daily living). These characteristics of the 6MWT are illustrated by the following studies:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective analysis of 440 patients from a randomized controlled trial with NYHA class III or IV HF symptoms, the 6MWT was associated with mortality (HR/100 m 0.58; 95% CI 0.5-0.68) and hospitalization (HR 0.85; 95% CI 0.46-0.90) [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Similarly, in a series of 476 patients from a single referral center, the distance walked at baseline was an independent predictor of two-year survival [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In HF-ACTION, changes in patient-reported health status by the Kansas City Cardiomyopathy Questionnaire (KCCQ) were weakly correlated with changes in functional capacity. A 5-point improvement in KCCQ was associated with a 112 m improvement in six-minute walk distance and a 2.5 mL/kg/min increase in peak VO
         <sub>
          2
         </sub>
         [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H32496488">
         <span class="h2">
          Exercise duration
         </span>
         <span class="headingEndMark">
          —
         </span>
         In HF ACTION, the most powerful predictor of the primary end point (death or all cause hospitalization) or death at median 2.5-year follow-up was exercise duration on a standardized baseline cardiopulmonary exercise test (Modified Naughton protocol) [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H32496435">
         <span class="h2">
          Ventilatory efficiency
         </span>
         <span class="headingEndMark">
          —
         </span>
         A possible alternative in patients who cannot achieve VO
         <sub>
          2
         </sub>
         max is measurement of the ventilatory efficiency, ie, ventilation-to-carbon dioxide production ratio in early exercise [
         <a href="#rid47">
          47-49
         </a>
         ]. During cardiopulmonary exercise testing, a close linear relationship exists between the production of CO
         <sub>
          2
         </sub>
         (VCO
         <sub>
          2
         </sub>
         ) and minute ventilation (VE). The slope of the regression line relating CO
         <sub>
          2
         </sub>
         production and minute ventilation (VE/VCO
         <sub>
          2
         </sub>
         ) can be used to describe the ventilatory response to exercise. In patients with HF, the VE/VCO
         <sub>
          2
         </sub>
         slope is easier to obtain than parameters of maximal exercise capacity and is a better predictor of outcome than VO
         <sub>
          2
         </sub>
         max, NYHA class, or LVEF [
         <a href="#rid43">
          43,49,50
         </a>
         ].
        </p>
        <p>
         HF is associated with an increase in VE due to increased dead space ventilation because of poor ventilation/perfusion matching, and an increase in VCO
         <sub>
          2
         </sub>
         relative to VO
         <sub>
          2
         </sub>
         resulting from bicarbonate buffering of lactic acid [
         <a href="#rid51">
          51
         </a>
         ]. A VE/VCO
         <sub>
          2
         </sub>
         regression line slope of &gt;34 is associated with reduced cardiac output during exercise, increased pulmonary artery wedge pressures, and reduced survival [
         <a href="#rid43">
          43,47
         </a>
         ]. In one report, patients with a VE/VCO
         <sub>
          2
         </sub>
         slope above 34 had more severe HF with significantly reduced survival during 18-month follow-up (69 versus 95 percent for those with lower values) (
         <a class="graphic graphic_figure graphicRef59902" href="/z/d/graphic/59902.html" rel="external">
          figure 7
         </a>
         ). In addition, an elevated VE/VCO
         <sub>
          2
         </sub>
         slope adds incremental prognostic value to both VO
         <sub>
          2
         </sub>
         max [
         <a href="#rid47">
          47,49
         </a>
         ] and the anaerobic threshold [
         <a href="#rid43">
          43
         </a>
         ], while a value above 44.7 adds incremental prognostic value to a low chronotropic index, which correlates with the peak heart rate achieved with exercise (
         <a class="graphic graphic_figure graphicRef66454" href="/z/d/graphic/66454.html" rel="external">
          figure 8
         </a>
         ) [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         An increase in VE/VCO
         <sub>
          2
         </sub>
         slope is also predictive of outcome in patients with preserved exercise capacity. Among 123 patients with a VO
         <sub>
          2
         </sub>
         max ≥18 mL/kg/min, the three year survival was significantly lower in those with a VE/VCO
         <sub>
          2
         </sub>
         ≥34 (57 versus 93 percent for VE/VCO
         <sub>
          2
         </sub>
         ≤34) [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H32496471">
         <span class="h2">
          Oxygen uptake efficiency parameters
         </span>
         <span class="headingEndMark">
          —
         </span>
         The oxygen uptake efficiency slope (OUES) is a parameter derived from VO
         <sub>
          2
         </sub>
         and VE [
         <a href="#rid54">
          54
         </a>
         ]. This parameter appears insensitive to the duration of exercise and correlates with outcomes in patients with advanced HF [
         <a href="#rid55">
          55
         </a>
         ]. These features suggest that OUES may be more useful than peak VO
         <sub>
          2
         </sub>
         , particularly in patients with limited exercise capacity for reasons other than HF.
        </p>
        <p>
         A preliminary study of 508 patients with HF with LVEF &lt;35 percent found that the highest plateau of oxygen uptake efficiency (OUEP) during incremental cardiopulmonary exercise was a stronger predictor of mortality at six months than VO
         <sub>
          2
         </sub>
         or six-minute walk distance [
         <a href="#rid56">
          56
         </a>
         ]. However, further validation of this finding is required.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Exercise hemodynamics
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not recommend the routine use of exercise hemodynamics [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          EXERCISE TRAINING IN HF
         </span>
         <span class="headingEndMark">
          —
         </span>
         A separate issue is the use of exercise training to improve symptoms in selected patients with HF (see
         <a class="medical medical_review" href="/z/d/html/3472.html" rel="external">
          "Cardiac rehabilitation in patients with heart failure"
         </a>
         ). Training does not improve cardiac function at rest, as estimated from LVEF, baseline cardiac output, or wedge pressure [
         <a href="#rid57">
          57
         </a>
         ]. It can, however, have the following benefits in both males and females [
         <a href="#rid58">
          58
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased peak VO
         <sub>
          2
         </sub>
         , peak cardiac output, and leg blood flow during exercise [
         <a href="#rid57">
          57,59
         </a>
         ]. These improvements may be related to an increase in peak early diastolic filling rate of the LV at rest and during exercise [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Improved muscle energetics so that oxygen utilization becomes more efficient, allowing a similar amount of work to be performed at a lower heart rate, rate-pressure product, and minute ventilation (indicating improved gas exchange) [
         <a href="#rid61">
          61,62
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reversal of the abnormalities in mitochondrial density and ultrastructure and on fiber type distribution in skeletal muscle seen with HF. For example, one study prospectively randomized 18 patients with HF to an ambulatory training or to a control group that was physically inactive [
         <a href="#rid63">
          63
         </a>
         ]. After six months, the patients who exercised had a significant increase in mitochondrial density and enhanced oxidative enzyme activity and a concomitant reshift to type I slow-twitch fibers. These changes appear to be unrelated to changes in peripheral perfusion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Partial reversal of endothelial dysfunction with restoration of endothelium-mediated flow-dependent dilation, possibly due to enhanced endothelial release of nitric oxide [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with an ischemic cardiomyopathy, there is an improvement in both thallium activity within the myocardium and the contractile response of dysfunctional myocardium to low dose
         <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">
          dobutamine
         </a>
         ; this correlates with an increase in collaterals [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reduction in plasma B-type natriuretic peptide values. (See
         <a class="medical medical_review" href="/z/d/html/3486.html" rel="external">
          "Natriuretic peptide measurement in heart failure"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         As a result, more exercise can be performed before reaching the anaerobic threshold (
         <a class="graphic graphic_figure graphicRef82041" href="/z/d/graphic/82041.html" rel="external">
          figure 9
         </a>
         ). In one study, for example, exercise training in stable patients with a mean LVEF of 20 percent led to an increase in peak VO
         <sub>
          2
         </sub>
         from 13.2 to 15.6 mL/kg/min [
         <a href="#rid57">
          57
         </a>
         ]. Another study reported that the improvement in VO
         <sub>
          2
         </sub>
         was not related to baseline central hemodynamics, but was greater in patients with a lower baseline VO
         <sub>
          2
         </sub>
         [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
         Thus, all three determinants of peak exercise - cardiac efficiency, pulmonary gas exchange, and skeletal muscle metabolism - may be improved by exercise training. The ability to perform more work with less energy expenditure may have the following benefits for the patient.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There may be an improvement in symptoms such as dyspnea and fatigue.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The lower rate-pressure product may allow patients with coronary disease to perform their daily tasks with fewer symptoms and less disability.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There may be a reduction in sympathetic tone and an increase in vagal tone at rest, thereby restoring autonomic cardiovascular control towards normal [
         <a href="#rid67">
          67
         </a>
         ]. To the degree that these changes reduce systemic vascular resistance and cardiac afterload, they may lead to an improvement in cardiac performance.
        </p>
        <p>
        </p>
        <p>
         There was previously no proof that improvement in peak VO
         <sub>
          2
         </sub>
         , as can be induced by exercise training, is associated with improvements in outcomes. In HF-ACTION, every 6 percent increase in peak VO
         <sub>
          2
         </sub>
         , adjusted for other significant predictors, was associated with a 5 percent lower risk of the primary end point, a 4 percent lower risk of the secondary end point of time to cardiovascular mortality or cardiovascular hospitalization, an 8 percent lower risk of cardiovascular mortality or HF hospitalization, and a 7 percent lower all-cause mortality [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
         Furthermore, there is sufficient evidence of an improvement in symptoms and exercise capacity that we recommend that all stable patients with symptomatic HF participate in an exercise training program [
         <a href="#rid57">
          57
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3472.html" rel="external">
          "Cardiac rehabilitation in patients with heart failure"
         </a>
         .)
        </p>
        <p>
         The impact of exercise programs on outcomes was studied in the HF ACTION trial, which is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3472.html" rel="external">
          "Cardiac rehabilitation in patients with heart failure"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1911960149">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115372.html" rel="external">
          "Society guideline links: Heart failure in adults"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/122212.html" rel="external">
          "Society guideline links: Stress testing and cardiopulmonary exercise testing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SUMMARY
         </span>
         <span class="headingEndMark">
          —
         </span>
         In clinical practice, many physicians follow the symptoms and signs of patients with heart failure (HF) as a guide to their course and prognosis. Nevertheless, serial assessment of maximal exercise capacity in patients with HF every three to six months is an important method to evaluate both the therapeutic response to pharmacologic intervention as well as prognosis. Determination of functional capacity is now an outpatient performance measure as published by the American Heart Association/American College of Cardiology Performance Measures for Chronic Heart Failure [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         Patients with mild HF (New York Heart Association [NYHA] class I or II) can be evaluated by repetitive treadmill exercise testing without a metabolic cart assessment for maximal oxygen consumption (ie, peak VO
         <sub>
          2
         </sub>
         ) (
         <a class="graphic graphic_table graphicRef52683" href="/z/d/graphic/52683.html" rel="external">
          table 2
         </a>
         ); in this setting, total exercise duration can be used as an objective measure of functional capacity.
        </p>
        <p>
         By comparison, patients who present with or progress to moderate to severe HF (NYHA class III or IV) should be referred for VO
         <sub>
          2
         </sub>
         testing. The specific method used to measure VO
         <sub>
          2
         </sub>
         is less important as long as the test is performed and interpreted in a consistent manner. Improved exercise capacity is often associated with an increase in peak VO
         <sub>
          2
         </sub>
         in these patients [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Working Group on Cardiac Rehabilitation &amp; Excercise Physiology and Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise testing in chronic heart failure patients. Eur Heart J 2001; 22:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corrà U, Piepoli MF, Adamopoulos S, et al. Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC. Eur J Heart Fail 2014; 16:929.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balady GJ, Arena R, Sietsema K, et al. Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010; 122:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2012; 126:2261.
          </a>
         </li>
         <li class="breakAll">
          Dennis C. Rehabilitation of patients with coronary artery disease. In: Heart Disease, A Textbook of Cardiovascular Medicine, 4th ed, Braunwald E (Ed), Saunders, Philadelphia 1992. p.1382.
         </li>
         <li>
          <a class="nounderline abstract_t">
           McElroy PA, Janicki JS, Weber KT. Cardiopulmonary exercise testing in congestive heart failure. Am J Cardiol 1988; 62:35A.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddy HK, Weber KT, Janicki JS, McElroy PA. Hemodynamic, ventilatory and metabolic effects of light isometric exercise in patients with chronic heart failure. J Am Coll Cardiol 1988; 12:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roul G, Germain P, Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J 1998; 136:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zugck C, Krüger C, Dürr S, et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 2000; 21:540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah MR, Hasselblad V, Gheorghiade M, et al. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2001; 88:987.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Passantino A, Lagioia R, Mastropasqua F, Scrutinio D. Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice. J Am Coll Cardiol 2006; 48:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997; 30:1758.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan MJ, Cobb FR. Central hemodynamic response to exercise in patients with chronic heart failure. Chest 1992; 101:340S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Del Buono MG, Arena R, Borlaug BA, et al. Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol 2019; 73:2209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colucci WS. In vivo studies of myocardial beta-adrenergic receptor pharmacology in patients with congestive heart failure. Circulation 1990; 82:I44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bristow MR, Minobe WA, Raynolds MV, et al. Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 1993; 92:2737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 1999; 34:1802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haykowsky MJ, Tomczak CR, Scott JM, et al. Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction. J Appl Physiol (1985) 2015; 119:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walsh JT, Andrews R, Johnson P, et al. Inspiratory muscle endurance in patients with chronic heart failure. Heart 1996; 76:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tikunov B, Levine S, Mancini D. Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation 1997; 95:910.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith AA, Cowburn PJ, Parker ME, et al. Impaired pulmonary diffusion during exercise in patients with chronic heart failure. Circulation 1999; 100:1406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988; 77:552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buller NP, Poole-Wilson PA. Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J 1990; 63:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Groote P, Dagorn J, Soudan B, et al. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 2004; 43:1584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stelken AM, Younis LT, Jennison SH, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996; 27:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant 2016; 35:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forman DE, Clare R, Kitzman DW, et al. Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study. Am Heart J 2009; 158:S6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elmariah S, Goldberg LR, Allen MT, Kao A. Effects of gender on peak oxygen consumption and the timing of cardiac transplantation. J Am Coll Cardiol 2006; 47:2237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009; 301:1439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cornelis J, Taeymans J, Hens W, et al. Prognostic respiratory parameters in heart failure patients with and without exercise oscillatory ventilation - a systematic review and descriptive meta-analysis. Int J Cardiol 2015; 182:476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corte RC, De Sá J, Carlos R, et al. Ventilation Dispersion Index as an Objective Evaluation Tool of Exercise Oscillatory Ventilation in Patients With Heart Failure. J Card Fail 2021; 27:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakade T, Adachi H, Murata M, Oshima S. Relationship Between Exercise Oscillatory Ventilation Loop and Prognosis of Heart Failure. Circ J 2019; 83:1718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guazzi M, Labate V, Cahalin LP, Arena R. Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction. Eur J Prev Cardiol 2014; 21:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palau P, Domínguez E, Núñez E, et al. Peak Exercise Oxygen Uptake Predicts Recurrent Admissions in Heart Failure With Preserved Ejection Fraction. Rev Esp Cardiol (Engl Ed) 2018; 71:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kitzman DW, Nicklas B, Kraus WE, et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol 2014; 306:H1364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kitzman DW, Haykowsky MJ, Tomczak CR. Making the Case for Skeletal Muscle Myopathy and Its Contribution to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail 2017; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss K, Schär M, Panjrath GS, et al. Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure. Circ Heart Fail 2017; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandey A, Patel KV, Vaduganathan M, et al. Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail 2018; 6:975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osada N, Chaitman BR, Miller LW, et al. Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol 1998; 31:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chomsky DB, Lang CC, Rayos GH, et al. Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation 1996; 94:3176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metra M, Faggiano P, D'Aloia A, et al. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 1999; 33:943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mancini D, Katz S, Donchez L, Aaronson K. Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure. Circulation 1996; 94:2492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002; 106:3079.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paraskevaidis IA, Adamopoulos S, Kremastinos DT. Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. J Am Coll Cardiol 2001; 37:1685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flynn KE, Lin L, Moe GW, et al. Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure. Am Heart J 2012; 163:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Connor CM, Whellan DJ, Wojdyla D, et al. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. Circ Heart Fail 2012; 5:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chua TP, Ponikowski P, Harrington D, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997; 29:1585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milani RV, Mehra MR, Reddy TK, et al. Ventilation/carbon dioxide production ratio in early exercise predicts poor functional capacity in congestive heart failure. Heart 1996; 76:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arena R, Myers J, Abella J, et al. Development of a ventilatory classification system in patients with heart failure. Circulation 2007; 115:2410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kleber FX, Vietzke G, Wernecke KD, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000; 101:2803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wasserman K, Zhang YY, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997; 96:2221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robbins M, Francis G, Pashkow FJ, et al. Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. Circulation 1999; 100:2411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baba R, Nagashima M, Goto M, et al. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 1996; 28:1567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davies LC, Wensel R, Georgiadou P, et al. Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. Eur Heart J 2006; 27:684.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun XG, Hansen JE, Stringer WW. Oxygen uptake efficiency plateau best predicts early death in heart failure. Chest 2012; 141:1284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swank AM, Horton J, Fleg JL, et al. Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circ Heart Fail 2012; 5:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tyni-Lenné R, Gordon A, Jansson E, et al. Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 80:1025.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85:2119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belardinelli R, Georgiou D, Cianci G, Purcaro A. Effects of exercise training on left ventricular filling at rest and during exercise in patients with ischemic cardiomyopathy and severe left ventricular systolic dysfunction. Am Heart J 1996; 132:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Minotti JR, Johnson EC, Hudson TL, et al. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 1990; 86:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adamopoulos S, Coats AJ, Brunotte F, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 1993; 21:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hambrecht R, Fiehn E, Yu J, et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 1997; 29:1067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belardinelli R, Georgiou D, Ginzton L, et al. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 1998; 97:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyer K, Görnandt L, Schwaibold M, et al. Predictors of response to exercise training in severe chronic congestive heart failure. Am J Cardiol 1997; 80:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coats AJ. Exercise rehabilitation in chronic heart failure. J Am Coll Cardiol 1993; 22:172A.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKelvie RS, Teo KK, McCartney N, et al. Effects of exercise training in patients with congestive heart failure: a critical review. J Am Coll Cardiol 1995; 25:789.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonow RO, Bennett S, Casey DE Jr, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 2005; 46:1144.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3503 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11133208" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Recommendations for exercise testing in chronic heart failure patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25175894" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20585013" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22952317" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22952317" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3133938" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Cardiopulmonary exercise testing in congestive heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3392326" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Hemodynamic, ventilatory and metabolic effects of light isometric exercise in patients with chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9736136" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10775009" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11703994" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16814655" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9385904" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Skeletal muscle function and its relation to exercise tolerance in chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1576862" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Central hemodynamic response to exercise in patients with chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31047010" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2164896" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : In vivo studies of myocardial beta-adrenergic receptor pharmacology in patients with congestive heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8254027" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10577573" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Pulmonary hypertension and exercise intolerance in patients with heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25911681" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8983680" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Inspiratory muscle endurance in patients with chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9054750" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10500041" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Impaired pulmonary diffusion during exercise in patients with chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3342486" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2126185" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15120815" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8557904" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26776864" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19782790" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16750689" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Effects of gender on peak oxygen consumption and the timing of cardiac transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19351941" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25616233" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Prognostic respiratory parameters in heart failure patients with and without exercise oscillatory ventilation - a systematic review and descriptive meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33038533" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Ventilation Dispersion Index as an Objective Evaluation Tool of Exercise Oscillatory Ventilation in Patients With Heart Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31257356" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Relationship Between Exercise Oscillatory Ventilation Loop and Prognosis of Heart Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23382540" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28666951" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Peak Exercise Oxygen Uptake Predicts Recurrent Admissions in Heart Failure With Preserved Ejection Fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24658015" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28705911" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Making the Case for Skeletal Muscle Myopathy and Its Contribution to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28705910" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30497652" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9502638" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8989126" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10091820" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8921793" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12473555" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11345385" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22172441" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22114101" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9180123" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8944583" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Ventilation/carbon dioxide production ratio in early exercise predicts poor functional capacity in congestive heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17452607" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Development of a ventilatory classification system in patients with heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10859285" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Impairment of ventilatory efficiency in heart failure: prognostic impact.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9337193" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Lung function and exercise gas exchange in chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10595953" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11181471" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8917273" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16338939" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22030802" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Oxygen uptake efficiency plateau best predicts early death in heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22773109" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9352972" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1591831" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8701877" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Effects of exercise training on left ventricular filling at rest and during exercise in patients with ischemic cardiomyopathy and severe left ventricular systolic dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2394829" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Skeletal muscle response to exercise training in congestive heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8459063" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Physical training improves skeletal muscle metabolism in patients with chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9120161" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8548890" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Physical training improves endothelial function in patients with chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9494025" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9205020" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Predictors of response to exercise training in severe chronic congestive heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8376689" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Exercise rehabilitation in chronic heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7860930" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Effects of exercise training in patients with congestive heart failure: a critical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16168305" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
